Respiratory Syncytial Virus (RSV) Trial

Description

We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes.

Criteria & Qualifications:
• Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.

Compensation:

Contact us for more information

Contact Us

    Additional information

    Patient Population

    ,

    Study Status

    Active